Authors
Latest:
Effects of an Integrated Medication Therapy Management Program in a Pioneer ACOThis article reports that an integrated medication management program in a Pioneer Accountable Care Organization was associated with decreases in all-cause hospitalization and Medicare costs.
Latest:
Genetic Counselors Save Costs Across the Genetic Testing SpectrumGenetic counselors (GCs) increasingly serve a variety of roles across the healthcare spectrum, including test utilization management. Our data show that utilizing the expertise of GCs reduced test order errors, improved patient outcomes, and resulted in significant cost savings to the healthcare system.
Latest:
The Use of Claims Data Algorithms to Recruit Eligible Participants Into Clinical TrialsUsing an ICD-9-CM code algorithm, the authors effectively identified potentially difficult-to-reach populations for a hypertension clinical trial.
Latest:
What the Data Can-and Can't-Say About PatientsDr. Vojta emphasized the importance of analyzing existing good patient data to improve care outcomes.
Latest:
Process, Cost, and Clinical Quality: The Initial Oral Contraceptive VisitLinking variation in process with cost and quality provides the opportunity for identifying low-cost, high-quality processes.
Latest:
Current Value-Based Care Models Need Greater Emphasis on Specialty CareThis article provides an overview of the impact of specialty care and the opportunity for it to leapfrog primary care as a lead focus for accountable care.
Latest:
Previously Unrecognized Trends in Diabetes Consumption Clusters in MedicareMedicare beneficiaries with diabetes who are at the lowest levels of healthcare consumption often become some of the highest level consumers in subsequent years.
Latest:
Radical Prostatectomy Innovation and Outcomes at Military and Civilian InstitutionsMinimally invasive radical prostatectomy was more commonly performed in civilian hospitals compared with military hospitals among TRICARE beneficiaries, with comparable postoperative outcomes.
Latest:
Patient Outcomes Associated With Tailored Hospital Programs for Intellectual DisabilitiesPatients with intellectual disabilities who were cared for in hospitals without programs tailored to intellectual disabilities had 6% higher costs, and those with extreme admission severity had 42% higher costs.
Latest:
Performance of the Adapted Diabetes Complications Severity Index Translated to ICD-10We present an International Classification of Diseases, Tenth Revision (ICD-10) translation of the adapted Diabetes Complications Severity Index and show its performance in predicting hospitalizations, mortality, and healthcare-associated costs.
Latest:
Evaluation of Care Management Intensity and Bariatric Surgical Weight LossThis study examines the effect of pre- and postoperative care management intensity on weight loss outcomes after bariatric surgery in 9 US centers.
Latest:
Impact of Certified CME in Atrial Fibrillation on Administrative ClaimsUse of administrative claims data is an innovative way of measuring the effect of continuing medical education on physician practice behavior and patient outcomes.
Latest:
Improving Adherence to Cardiovascular Disease Medications With Information TechnologyImproving adherence to long-term medication therapy remains a challenge. Health information technology interventions that leverage electronic medical records are promising, low-cost approaches for increasing adherence.
Latest:
Florida Blue Program Focuses on Weight Loss - and Fun - to Prevent Type 2 Diabetes in Older AdultsHow does the largest payer in a state with a large senior population respond to the rising need for diabetes care and prevention?
Latest:
General Medical Claims for Behavioral Health Patients in JapanThis Japanese cohort shows that behavioral health service users had health care costs higher than those of individuals who did not use behavioral health services, yet lower than the costs demonstrated by studies in US populations.
Latest:
Personalized Medicine: On the Brink of Revolutionizing Cancer CareWith unprecedented activity in the area of precision medicine, with the successful development of several targeted therapies, the FDA has been in the forefront of efforts to ensure timely access to, and the safe and effective use of, these therapies.
Latest:
Cost-effectiveness of Nivolumab in Patients With NSCLC in the United StatesThis article presents a cost-effectiveness analysis of nivolumab vs docetaxel from the US payer perspective in non–small cell lung cancer (NSCLC) based on randomized phase 3 studies with a minimum 5 years of follow-up.
Latest:
Association of Care Management Intensity With Healthcare Utilization in an All-Condition Care Management ProgramHigher intensity of care management in an all-condition program addressing care coordination and care barriers was associated with increased healthcare utilization among Medicaid and Medicare patients.
